As of Jan 13
| -0.05 / -1.18%|
The 8 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 7.50, with a high estimate of 13.00 and a low estimate of 4.50. The median estimate represents a +78.57% increase from the last price of 4.20.
The current consensus among 8 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.